Search research articles
Contact Us
Filters
Showing results (11-20 of 200) with videos related to
Page
of 20
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2024
Total loss of <i>VHL</i> gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity
Muhannad Abu-Remaileh, Nicole S Persky, Yenarae Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 24, 2014
Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease
Reut Shema, Ruth Kulicke, Glenn S Cowley, et al.
Journal of Biomolecular Screening
|
September 22, 2016
High-Throughput Platform for Identifying Molecular Factors Involved in Phenotypic Stabilization of Primary Human Hepatocytes In Vitro
Jing Shan, David J Logan, David E Root, et al.
Molecular Cancer Therapeutics
|
September 10, 2015
Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors
Steven R Whittaker, Glenn S Cowley, Steve Wagner, et al.
The Journal of Biological Chemistry
|
April 19, 2020
Correction: Mitochondrial and nuclear genomic responses to loss of <i>LRPPRC</i> expression
Vishal M Gohil, Roland Nilsson, Casey A Belcher-Timme, et al.
The Journal of Biological Chemistry
|
March 12, 2010
Mitochondrial and nuclear genomic responses to loss of LRPPRC expression
Vishal M Gohil, Roland Nilsson, Casey A Belcher-Timme, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2003
Conserved pathways within bacteria and yeast as revealed by global protein network alignment
Brian P Kelley, Roded Sharan, Richard M Karp, et al.
Chemistry & Biology
|
November 24, 2004
A flexible data analysis tool for chemical genetic screens
Brian P Kelley, Mitchell R Lunn, David E Root, et al.
Molecular Cancer Therapeutics
|
May 7, 2020
A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer
Charlotte K Milton, Annette J Self, Paul A Clarke, et al.
Plos One
|
January 25, 2017
Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool
Katherine F Donovan, Mudra Hegde, Meagan Sullender, et al.
Page
of 20
Search research articles
Search
Showing results (11-20 of 200) with videos related to
Sort By:
Page
of 20
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2024
Total loss of <i>VHL</i> gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity
Muhannad Abu-Remaileh, Nicole S Persky, Yenarae Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 24, 2014
Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington's disease
Reut Shema, Ruth Kulicke, Glenn S Cowley, et al.
Journal of Biomolecular Screening
|
September 22, 2016
High-Throughput Platform for Identifying Molecular Factors Involved in Phenotypic Stabilization of Primary Human Hepatocytes In Vitro
Jing Shan, David J Logan, David E Root, et al.
Molecular Cancer Therapeutics
|
September 10, 2015
Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors
Steven R Whittaker, Glenn S Cowley, Steve Wagner, et al.
The Journal of Biological Chemistry
|
April 19, 2020
Correction: Mitochondrial and nuclear genomic responses to loss of <i>LRPPRC</i> expression
Vishal M Gohil, Roland Nilsson, Casey A Belcher-Timme, et al.
The Journal of Biological Chemistry
|
March 12, 2010
Mitochondrial and nuclear genomic responses to loss of LRPPRC expression
Vishal M Gohil, Roland Nilsson, Casey A Belcher-Timme, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 25, 2003
Conserved pathways within bacteria and yeast as revealed by global protein network alignment
Brian P Kelley, Roded Sharan, Richard M Karp, et al.
Chemistry & Biology
|
November 24, 2004
A flexible data analysis tool for chemical genetic screens
Brian P Kelley, Mitchell R Lunn, David E Root, et al.
Molecular Cancer Therapeutics
|
May 7, 2020
A Genome-scale CRISPR Screen Identifies the ERBB and mTOR Signaling Networks as Key Determinants of Response to PI3K Inhibition in Pancreatic Cancer
Charlotte K Milton, Annette J Self, Paul A Clarke, et al.
Plos One
|
January 25, 2017
Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool
Katherine F Donovan, Mudra Hegde, Meagan Sullender, et al.
Page
of 20